March 31, 2015 8:21 AM 1 min read

Benzinga's Top #PreMarket Losers

by Monica Gerson Benzinga Staff Writer
Follow
Synta Pharmaceuticals Corp. SNTA
shares declined 16.74% to $1.94 in pre-market trading. Synta Pharmaceuticals launched a public offering of its shares.
Celladon Corporation CLDN
fell 6.23% to $20.32 in pre-market trading. Celladon reported a Q4 consolidated loss of $11.34 million.
Insmed Incorporated
Earn 7.2% — No Matter What the Fed Does
Earn 7.2% — No Matter What the Fed Does

Markets expect rate cuts — but your earnings don’t have to suffer. Lock in 7.2% until 2028 from ten individual bonds.

INSM
slipped 3.89% to $20.27 in pre-market trading after the company announced a public offering of 10 million shares of common stock.
Lorillard, Inc.LO
shares dropped 2.15% to $64.99 in pre-market following the NY Post report FTC has recommended a lawsuit to block merger of Reynolds American and Lorillard.
Reynolds American Inc. RAI
shares fell 2.12% to $68.00 in pre-market trading following the NY Post report FTC has recommended a lawsuit to block merger of Reynolds American and Lorillard.
Loading...
Loading...
INSM Logo
INSMInsmed Inc
$68.121.34%

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings
Edge Rankings
Momentum
96.92
Growth
-
Quality
-
Value
9.01
Price Trend
Short
Medium
Long
Overview
Market News and Data brought to you by Benzinga APIs

© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Posted In:
NewsMovers & ShakersPre-Market OutlookMarketsConsumer StaplesTobaccoTop Losers
Comments

Connect With Us

instagramlinkedinyoutube

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell

© 2025 Benzinga | All Rights Reserved